Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry

Fig. 1

Event rates of all-cause mortality, cardiovascular (CV) mortality, congestive heart failure (CHF), non-fatal stroke, and non-fatal myocardial infarction (MI) in patients who received guideline-recommended β-blockers and patients who received non-guideline-recommended β-blockers. The use of non-guideline-recommended β-blockers rather than guideline recommended β-blockers were associated with increased with 1-year CV mortality (P < 0.05)

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us